Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Verger · SciRah

Researcher profile · Semantic Scholar

E. Verger

Share profile

E. Verger — researcher profile on SciRah

h-index: 18
Works: 53
Citations: 1,395

Most-cited papers

Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network
A. Caye, M. Strullu, F. Guidez, B. Cassinat +29 more
2015Nature Genetics185 citations
Semantic Scholar
Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations.
E. Verger, B. Cassinat, A. Chauveau, C. Dosquet +10 more
2015Blood159 citations
Semantic Scholar
Synergistic effects of PRIMA-1Met (APR-246) and 5-azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia
N. Maslah, N. Salomao, L. Drevon, E. Verger +13 more
2019Haematologica123 citations Open access
Semantic Scholar
The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders
N. Maslah, B. Cassinat, E. Verger, J. Kiladjian +1 more
2017Leukemia110 citations
Semantic Scholar
Pathophysiological insights in sickle cell disease
M. Odièvre, E. Verger, A. C. Silva-Pinto, J. Elion
2011The Indian journal of medical research108 citations
Semantic Scholar
Interferon alfa therapy in CALR-mutated essential thrombocythemia.
B. Cassinat, E. Verger, J. Kiladjian
2014New England Journal of Medicine83 citations Open access
Semantic Scholar
Endothelial Cells Harbouring the JAK2V617F Mutation Display Pro-Adherent and Pro-Thrombotic Features
Anna Guadall, E. Lesteven, G. Letort, Sarah Awan Toor +12 more
2018Thrombosis and Haemostasis79 citations Open access
Semantic Scholar
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.
D. Luque Paz, J. Riou, E. Verger, B. Cassinat +39 more
2021Blood Advances71 citations Open access
Semantic Scholar
Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo
E. Verger, J. Soret-Dulphy, N. Maslah, L. Roy +10 more
2018Blood Cancer Journal55 citations Open access
Semantic Scholar
Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses.
P. Debureaux, B. Cassinat, J. Soret-Dulphy, B. Mora +13 more
2020Blood Advances41 citations Open access
Semantic Scholar
Interferon-Alpha (IFN) Therapy Discontinuation Is Feasible in Myeloproliferative Neoplasm (MPN) Patients with Complete Hematological Remission
Rafael Daltro de Oliveira, J. Soret-Dulphy, Lin-Pierre Zhao, C. Marcault +10 more
202037 citations Open access
Semantic Scholar
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification
Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, J. Soret-Dulphy +19 more
2023Leukemia35 citations
Semantic Scholar
Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms (MPN).
C. Marcault, Lin-Pierre Zhao, Nabih Maslah, E. Verger +15 more
2021Blood34 citations Open access
Semantic Scholar
Quantification of the Mutant CALR Allelic Burden by Digital PCR: Application to Minimal Residual Disease Evaluation after Bone Marrow Transplantation.
Olivier Mansier, Marina Migeon, A. Saint-Lézer, C. James +7 more
2016Journal of Molecular Diagnostics34 citations Open access
Semantic Scholar
JAK2V617F myeloproliferative neoplasm eradication by a novel interferon/arsenic therapy involves PML
Tracy Dagher, Nabih Maslah, V. Edmond, B. Cassinat +10 more
2020Journal of Experimental Medicine32 citations Open access
Semantic Scholar
Single-cell analysis reveals selection of TP53-mutated clones after MDM2 inhibition
Nabih Maslah, E. Verger, S. Giraudier, Mathias Chéa +4 more
2022Blood Advances27 citations Open access
Semantic Scholar
Next-generation sequencing for JAK2 mutation testing: advantages and pitfalls
N. Maslah, E. Verger, M. Schlageter, J. Miclea +4 more
2018Annals of Hematology27 citations
Semantic Scholar
Hydroxycarbamide stimulates the production of proinflammatory cytokines by endothelial cells: relevance to sickle cell disease
S. Laurance, F. Pellay, O. P. Dossou-Yovo, E. Verger +4 more
2010Pharmacogenetics & Genomics20 citations
Semantic Scholar
Protein dysregulation in mouse hippocampus polytransgenic for chromosome 21 structures in the Down Syndrome Critical Region.
Joo-Ho Shin, T. Gulesserian, E. Verger, J. Delabar +1 more
2006Journal of Proteome Research17 citations
Semantic Scholar
Clinical Resistance To Ruxolitinib Is More Frequent In Patients Without MPN-Associated Mutations and Is Rarely Due To Mutations In The JAK2 Kinase Drug-Binding Domain
A. Andreoli, E. Verger, M. Robin, E. Raffoux +9 more
201314 citations
Semantic Scholar
Prior exposure of endothelial cells to hydroxycarbamide alters the flow dynamics and adhesion of sickle red blood cells
E. Verger, Damien Schoëvaërt, P. Carrivain, J. Victor +2 more
2014Clinical Hemorheology and Microcirculation11 citations
Semantic Scholar
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC‐PM
Matteo Guerra, Hélène Pasquer, Rafael Daltro de Oliveira, J. Soret-Dulphy +13 more
2024American journal of hematology/oncology10 citations Open access
Semantic Scholar
SF3B1 mutations in the Driver Clone Increase the Risk of Evolution to Myelofibrosis in Patients with Myeloproliferative Neoplasms (MPN)
Lin-Pierre Zhao, Rafael Daltro de Oliveira, C. Marcault, J. Soret +14 more
202010 citations
Semantic Scholar
Revisiting Diagnostic performances of serum erythropoïetin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement
N. Maslah, Odonchimeg Ravdan, L. Drevon, E. Verger +6 more
2021British Journal of Haematology9 citations
Semantic Scholar
CCND2 mutations are infrequent events in BCR-ABL1 negative myeloproliferative neoplasm patients
B. Cassinat, E. Verger, N. Maslah, N. Gauthier +3 more
2020Haematologica8 citations Open access
Semantic Scholar
Pitfalls in CALR exon 9 mutation detection: A single‐center experience in 571 positive patients
E. Verger, N. Maslah, M. Schlageter, C. Chomienne +3 more
2020International Journal of Laboratory Hematology7 citations
Semantic Scholar
Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID)
D. Elessa, Lin-Pierre Zhao, R. de Oliveira, N. Maslah +13 more
2023Leukemia6 citations
Semantic Scholar
Specific and Synergistic Targeting of JAK2V617F Cells By Interferon Alpha and Arsenic
N. Maslah, Tracy Dagher, V. Edmond, B. Cassinat +6 more
2018Blood6 citations Open access
Semantic Scholar
Low incidence of CALR gene mutations in patients with cerebral venous thrombosis without overt chronic myeloproliferative neoplasm.
E. Verger, I. Crassard, B. Cassinat, S. Bellucci
2015Thrombosis Research6 citations
Semantic Scholar
JAK Inhibition Mediates Clonal Selection of RAS Pathway Mutations in Myeloproliferative Neoplasms
N. Maslah, Blandine Roux, N. Kaci, E. Verger +17 more
2022Blood5 citations Open access
Semantic Scholar
Myeloproliferative Neoplasms (MPN) Clonal Evolution Landscape and Its Impact on Patients' Prognosis
Lin-Pierre Zhao, M. Cazaux, N. Maslah, Rafael Daltro de Oliveira +11 more
2021Blood5 citations Open access
Semantic Scholar
Unexplained thrombocytosis: association of Baltimore polymorphism with germline MPL nonsense mutation
E. Verger, F. Teillet, Carole Conejero, G. Letort +3 more
2016British Journal of Haematology5 citations Open access
Semantic Scholar
A molecular signature predicts hematologic evolution in polycythemia vera patients
Olivier Mansier, Eric Lippert, L. Benajiba, D. Ranta +30 more
2025Leukemia4 citations Open access
Semantic Scholar
Chemotherapy for post-myelofibrosis acute myeloid leukemia: eradication of the leukemic clone but not the MPN clone
E. Verger, E. Rattarittamrong, G. Letort, E. Raffoux +2 more
2017Leukemia and Lymphoma4 citations
Semantic Scholar
SH2B3 Loss of Function Variants Are Potential Drivers of Severe Thrombocytosis
Sarah Awan-Toor, Jimena Castorena, D. Clay, J. Soret-Dulphy +12 more
2024Blood2 citations
Semantic Scholar
Chronic Exposure to Cytoreductive Treatment Shapes Clonal Evolution in Myeloproliferative Neoplasms
Lin-Pierre Zhao, N. Maslah, Rafael Daltro de Oliveira, E. Verger +11 more
2021Blood2 citations
Semantic Scholar
NFE2 Mutations Impact AML Transformation and Overall Survival in Patients with Myeloproliferative Neoplasms (MPN)
C. Marcault, Lin-Pierre Zhao, Rafael Daltro de Oliveira, J. Soret +14 more
20202 citations Open access
Semantic Scholar
Genomic Landscape and Clinical Features of Myeloproliferative Neoplasm (MPN) Patients with Auto-Immune and Inflammatory Diseases (AID)
D. Elessa, Lin-Pierre Zhao, Rafael Daltro de Oliveira, N. Maslah +13 more
2021Blood1 citations
Semantic Scholar
Expansion of Prior Existing TP53 Mutated Clones in Polycythemia Vera Patients Treated with Idasanutlin
B. Marcellino, B. Cassinat, N. Farnoud, Min Lu +12 more
2019Blood1 citations Open access
Semantic Scholar
Significant Impact of the Molecular Profile on the Prognosis of Patients with Myeloproliferative Neoplasms and Splanchnic Vein Thromboses
P. Debureaux, B. Cassinat, J. Soret-Dulphy, E. Verger +6 more
2019Blood1 citations
Semantic Scholar
JAK2V617F - Positive Endothelial Cells Display Pro-Thrombotic Characteristics
Anna Guadall, E. Lesteven, G. Letort, S. A. Toor +9 more
20161 citations
Semantic Scholar
TET2 gene sequencing may be helpful for myeloproliferative neoplasm diagnosis
E. Verger, A. Andreoli, C. Chomienne, J. Kiladjian +1 more
2014British Journal of Haematology1 citations Open access
Semantic Scholar
Impact of the Molecular Profile of Malignant Clones on the Response to Interferon Alpha (IFNa) Therapy in JAK2V617F-Negative Essential Thrombocythemia (ET)
E. Verger, B. Cassinat, C. Dosquet, M. Schlageter +7 more
20141 citations
Semantic Scholar
GATA-2 and GATA-6 Involvement in Hydroxycarbamide Action On Endothelial Cells in Sickle Cell Disease.
Pauline Lansiaux, S. Laurance, M. Hauchecorne, E. Verger +2 more
20091 citations
Semantic Scholar
Genetic screening of triple negative thrombocytosis patients identifies germline MPL compound mutations and SH2B3/LNK truncating mutations.
B. Cassinat, Louise Lecordier, Sarah Awan-Toor, D. Clay +19 more
2026Haematologica0 citations Open access
Semantic Scholar
POS0954 CLINICAL FEATURES AND GENOMIC LANDSCAPE OF MYELOPROLIFERATIVE NEOPLASM (MPN) PATIENTS WITH AUTOIMMUNE AND INFLAMMATORY DISEASES
D. Elessa, L.-P. Zhao, R. de Oliveira, N. Maslah +13 more
2023Annals of the Rheumatic Diseases0 citations Open access
Semantic Scholar
Distinct Clinico-Molecular Arterial and Venous Thrombotic Scoring Systems for MPN Patients Risk Stratification
Hélène Pasquer, Rafael Daltro de Oliveira, J. Soret, N. Maslah +12 more
2022Blood0 citations Open access
Semantic Scholar
Outcomes of Patients with Myeloproliferative Neoplasms (MPN) after Interferon-Alpha (IFN) Therapy Discontinuation
J. Soret, B. Cassinat, S. Chevret, C. Dosquet +6 more
20160 citations
Semantic Scholar
MYELOID NEOPLASIA Clinical and molecular response to interferon- a therapy in essential thrombocythemia patients with CALR mutations
E. Verger, B. Cassinat, A. Chauveau, C. Dosquet +10 more
20150 citations
Semantic Scholar
Impact of the JAK2V617F Mutation on the Hemato-Endothelial Differentiation in an Induced Pluripotent Stem Cells (iPSC) Model
E. Lesteven, Doriane Pognant, V. Vanneaux, J. Larghero +7 more
20140 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

B. Cassinat×45
Invite
B. Cassinat — researcher profile on SciRah
J. Kiladjian×38
Invite
J. Kiladjian — researcher profile on SciRah
S. Giraudier×29
Invite
S. Giraudier — researcher profile on SciRah
N. Maslah×23
Invite
N. Maslah — researcher profile on SciRah

×16

Invite

C. Chomienne — researcher profile on SciRah

L. Benajiba×16

Invite

L. Benajiba — researcher profile on SciRah

Invite

N. Parquet — researcher profile on SciRah

J. Soret-Dulphy×14

Invite

J. Soret-Dulphy — researcher profile on SciRah

Invite

E. Raffoux — researcher profile on SciRah

Rafael Daltro de Oliveira×12

Invite

Rafael Daltro de Oliveira — researcher profile on SciRah

C. Marcault×12

Invite

C. Marcault — researcher profile on SciRah

W. Vainchenker×10

Invite

W. Vainchenker — researcher profile on SciRah